That barrier could now fall sharply
We calculated the monthly percentage of patients who met our inclusion criteria and who received a prescription for AOM liraglutide or AOM semaglutide within the 10 days prior or 100 days after the BMI event
You do not need to show them ahead of time
Both make sign-up simple, but they differ in how much behavioral and clinical support is built into the program
Potential health benefits: Weight loss achieved with GLP-1 medications may improve glycemic control, reduce blood pressure, decrease cholesterol levels, and lower the risk of certain obesity-related complications
It is a selective GLP-1 receptor agonist, and all of its reported metabolic effects trace back to GLP-1 receptor activation, whether in the pancreas, the hypothalamus and hindbrain, or the gut